T. Rowe Price Associates
CTVA icon

T. Rowe Price Associates’s Corteva CTVA Stock Holding History

T. Rowe Price Associates’s Portfolio CTVA Stock Details CTVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$411M Sell
4,848,689
-387,243
-7% -$31.1M 0.04% 319
2026
Q1 		$438M Buy
5,235,932
+2,101,260
+67% +$158M 0.05% 272
2025
Q4 		$210M Sell
3,134,672
-152,058
-5% -$9.83M 0.02% 448
2025
Q3 		$222M Sell
3,286,730
-68,720
-2% -$4.98M 0.02% 434
2025
Q2 		$250M Buy
3,355,450
+104,001
+3% +$6.93M 0.03% 386
2025
Q1 		$205M Buy
3,251,449
+1,290,009
+66% +$79.8M 0.03% 411
2024
Q4 		$112M Buy
1,961,440
+967,118
+97% +$57.2M 0.01% 549
2024
Q3 		$58.5M Sell
994,322
-12,943
-1% -$707K 0.01% 713
2024
Q2 		$54.3M Buy
1,007,265
+23,349
+2% +$1.29M 0.01% 697
2024
Q1 		$56.7M Buy
983,916
+4,498
+0.5% +$232K 0.01% 697
2023
Q4 		$46.9M Buy
979,418
+4,253
+0.4% +$203K 0.01% 730
2023
Q3 		$49.9M Sell
975,165
-226,999
-19% -$12M 0.01% 681
2023
Q2 		$68.9M Sell
1,202,164
-52,910
-4% -$3.09M 0.01% 615
2023
Q1 		$75.7M Sell
1,255,074
-2,678,516
-68% -$164M 0.01% 578
2022
Q4 		$231M Sell
3,933,590
-1,245,476
-24% -$78.8M 0.04% 348
2022
Q3 		$296M Sell
5,179,066
-3,337,255
-39% -$194M 0.05% 302
2022
Q2 		$461M Sell
8,516,321
-1,692,775
-17% -$98.3M 0.06% 307
2022
Q1 		$587M Buy
10,209,096
+1,571,444
+18% +$80.3M 0.06% 299
2021
Q4 		$408M Sell
8,637,652
-62,317
-0.7% -$2.84M 0.04% 386
2021
Q3 		$366M Buy
8,699,969
+571,589
+7% +$24.7M 0.03% 403
2021
Q2 		$360M Buy
8,128,380
+72,805
+0.9% +$3.36M 0.03% 411
2021
Q1 		$376M Sell
8,055,575
-95,672
-1% -$4.23M 0.04% 393
2020
Q4 		$316M Sell
8,151,247
-179,185
-2% -$6.4M 0.03% 411
2020
Q3 		$240M Sell
8,330,432
-81,165
-1% -$2.29M 0.03% 444
2020
Q2 		$225M Buy
8,411,597
+1,147
+0% +$29.8K 0.03% 448
2020
Q1 		$198M Sell
8,410,450
-3,239,689
-28% -$89.1M 0.03% 417
2019
Q4 		$344M Sell
11,650,139
-1,666,618
-13% -$44.1M 0.04% 360
2019
Q3 		$373M Sell
13,316,757
-348,137
-3% -$10.1M 0.05% 332
2019
Q2 		$404M Buy
+13,664,894
New +$368M 0.06% 313

Other funds holding CTVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

T. Rowe Price Associates's CTVA Position: Q2 2026 in Review

T. Rowe Price Associates reduced its Corteva (CTVA) stake by 7.4% in Q2 2026, selling an estimated $31.1M and leaving 4,848,689 shares worth $411M. The position accounts for 0.04% of the portfolio, ranked #319.

T. Rowe Price Associates first reported a position in CTVA in Q2 2019 and has held it in 29 quarters since. The position peaked at $587M in Q1 2022. 1,491 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • T. Rowe Price Associates held 4,848,689 shares of Corteva worth $411M as of Q2 2026.
  • T. Rowe Price Associates sold 387,243 Corteva shares in Q2 2026, an estimated $31.1M.
  • Corteva made up 0.04% of T. Rowe Price Associates's portfolio in Q2 2026, its #319 holding.
  • T. Rowe Price Associates first reported a position in Corteva in Q2 2019 and has held it in 29 quarters since.
  • T. Rowe Price Associates's Corteva position peaked at $587M in Q1 2022.
  • 1,491 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.